AnchorDx's Series A - II Round

AnchorDx raised a round of funding on January 01, 2016. Investors include Marathon Venture Partners (远毅资本).

AnchorDx (基准医疗) is a precision medicine company engaged in the clinical research & development of targeted DNA methylation high-throughput sequencing solutions for the early diagnosis of cance…

Articles about AnchorDx's Series A - II Round: